<SEC-DOCUMENT>0000950170-24-139356.txt : 20241223
<SEC-HEADER>0000950170-24-139356.hdr.sgml : 20241223
<ACCEPTANCE-DATETIME>20241223111120
ACCESSION NUMBER:		0000950170-24-139356
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241223
DATE AS OF CHANGE:		20241223

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AIM ImmunoTech Inc.
		CENTRAL INDEX KEY:			0000946644
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				520845822
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-48691
		FILM NUMBER:		241571082

	BUSINESS ADDRESS:	
		STREET 1:		2117 SW HIGHWAY 484
		CITY:			OCALA
		STATE:			FL
		ZIP:			32801
		BUSINESS PHONE:		352-448-7797

	MAIL ADDRESS:	
		STREET 1:		2117 SW HIGHWAY 484
		CITY:			OCALA
		STATE:			FL
		ZIP:			32801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEMISPHERX BIOPHARMA INC
		DATE OF NAME CHANGE:	19950614

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Deutsch Todd
		CENTRAL INDEX KEY:			0001709836
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		100 JERICHO QUADRANGLE, SUITE 100
		CITY:			JERICHO
		STATE:			NY
		ZIP:			11753
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>SCHEDULE 13D/A</submissionType>
<previousAccessionNumber>0001193125-23-196184</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001709836</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>10</amendmentNo>
<securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
<dateOfEvent>12/19/2024</dateOfEvent>
<previouslyFiledFlag>false</previouslyFiledFlag>
<issuerInfo>
<issuerCIK>0000946644</issuerCIK>
<issuerCUSIP>00901B105</issuerCUSIP>
<issuerName>AIM IMMUNOTECH INC.</issuerName>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">2117 SW HIGHWAY 484</street1>
<city xmlns="http://www.sec.gov/edgar/common">OCALA</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">FL</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">32801</zipCode>
</address>
</issuerInfo>
<authorizedPersons>
<notificationInfo>
<personName>Todd Deutsch</personName>
<personPhoneNum>(216) 621-0200</personPhoneNum>
<personAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">c/o Baker &amp; Hostetler LLP, 127 Public Sq</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 2000 Attn: John J. Harrington</street2>
<city xmlns="http://www.sec.gov/edgar/common">Cleveland</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">OH</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">44114</zipCode>
</personAddress>
</notificationInfo>
<notificationInfo>
<personName>Ted D. Kellner</personName>
<personPhoneNum>(216) 621-0200</personPhoneNum>
<personAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">c/o Baker &amp; Hostetler LLP, 127 Public Sq</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 2000 Attn: John J. Harrington</street2>
<city xmlns="http://www.sec.gov/edgar/common">Cleveland</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">OH</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">44114</zipCode>
</personAddress>
</notificationInfo>
<notificationInfo>
<personName>Paul W. Sweeney</personName>
<personPhoneNum>(216) 621-0200</personPhoneNum>
<personAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">c/o Baker &amp; Hostetler LLP, 127 Public Sq</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 2000 Attn: John J. Harrington</street2>
<city xmlns="http://www.sec.gov/edgar/common">Cleveland</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">OH</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">44114</zipCode>
</personAddress>
</notificationInfo>
<notificationInfo>
<personName>Wayne Springate</personName>
<personPhoneNum>(216) 621-0200</personPhoneNum>
<personAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">c/o Baker &amp; Hostetler LLP, 127 Public Sq</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 2000 Attn: John J. Harrington</street2>
<city xmlns="http://www.sec.gov/edgar/common">Cleveland</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">OH</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">44114</zipCode>
</personAddress>
</notificationInfo>
</authorizedPersons>
</coverPageHeader>
<reportingPersons>
<reportingPersonInfo>
<reportingPersonCIK>0001709836</reportingPersonCIK>
<reportingPersonNoCIK>N</reportingPersonNoCIK>
<reportingPersonName>Todd Deutsch</reportingPersonName>
<memberOfGroup>b</memberOfGroup>
<fundType>PF</fundType>
<legalProceedings>N</legalProceedings>
<citizenshipOrOrganization>X1</citizenshipOrOrganization>
<soleVotingPower>1716100</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>1716100</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
<aggregateAmountOwned>1716100</aggregateAmountOwned>
<isAggregateExcludeShares>Y</isAggregateExcludeShares>
<percentOfClass>2.7</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<commentContent>Percentage ownership based on 63,779,325 shares outstanding as reported in a Prospectus filed by the Company pursuant to Rule 424(b)(5) on December 4, 2024 with the Securities and Exchange Commission (File No. 333-283269).</commentContent>
</reportingPersonInfo>
<reportingPersonInfo>
<reportingPersonCIK>0001187524</reportingPersonCIK>
<reportingPersonNoCIK>N</reportingPersonNoCIK>
<reportingPersonName>Ted D. Kellner</reportingPersonName>
<memberOfGroup>b</memberOfGroup>
<fundType>PF</fundType>
<legalProceedings>N</legalProceedings>
<citizenshipOrOrganization>X1</citizenshipOrOrganization>
<soleVotingPower>394000</soleVotingPower>
<sharedVotingPower>1099000</sharedVotingPower>
<soleDispositivePower>394000</soleDispositivePower>
<sharedDispositivePower>1099000</sharedDispositivePower>
<aggregateAmountOwned>1493000</aggregateAmountOwned>
<isAggregateExcludeShares>Y</isAggregateExcludeShares>
<percentOfClass>2.3</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<commentContent>Percentage ownership based on 63,779,325 shares outstanding as reported in a Prospectus filed by the Company pursuant to Rule 424(b)(5) on December 4, 2024 with the Securities and Exchange Commission (File No. 333-283269).</commentContent>
</reportingPersonInfo>
<reportingPersonInfo>
<reportingPersonNoCIK>Y</reportingPersonNoCIK>
<reportingPersonName>Paul W. Sweeney</reportingPersonName>
<memberOfGroup>b</memberOfGroup>
<fundType>PF</fundType>
<legalProceedings>N</legalProceedings>
<citizenshipOrOrganization>X1</citizenshipOrOrganization>
<soleVotingPower>2000</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>2000</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
<aggregateAmountOwned>2000</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>0</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<commentContent>Percentage ownership based on 63,779,325 shares outstanding as reported in a Prospectus filed by the Company pursuant to Rule 424(b)(5) on December 4, 2024 with the Securities and Exchange Commission (File No. 333-283269). </commentContent>
</reportingPersonInfo>
<reportingPersonInfo>
<reportingPersonCIK>0001465652</reportingPersonCIK>
<reportingPersonNoCIK>N</reportingPersonNoCIK>
<reportingPersonName>Wayne Springate</reportingPersonName>
<memberOfGroup>b</memberOfGroup>
<legalProceedings>N</legalProceedings>
<citizenshipOrOrganization>X1</citizenshipOrOrganization>
<soleVotingPower>4660</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>4660</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
<aggregateAmountOwned>4660</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>0.01</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<commentContent>Percentage ownership based on 63,779,325 shares outstanding as reported in a Prospectus filed by the Company pursuant to Rule 424(b)(5) on December 4, 2024 with the Securities and Exchange Commission (File No. 333-283269). </commentContent>
</reportingPersonInfo>
</reportingPersons>
<items1To7>
<item1>
<securityTitle>Common Stock, par value $0.001 per share</securityTitle>
<issuerName>AIM IMMUNOTECH INC.</issuerName>
<issuerPrincipalAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">2117 SW HIGHWAY 484</street1>
<city xmlns="http://www.sec.gov/edgar/common">OCALA</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">FL</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">32801</zipCode>
</issuerPrincipalAddress>
<commentText>This Amendment No. 10 ("Amendment No. 10") is being filed jointly by Todd Deutsch, Ted. D. Kellner, Paul W. Sweeney and Wayne Springate and amends and supplements the Schedule 13D filed with the Securities and Exchange Commission on July 27, 2023 (the "Initial Schedule 13D" and together with Amendment No. 1 thereto filed on August 7, 2023, Amendment No. 2 thereto filed on August 28, 2023, Amendment No. 3 thereto filed on January 3, 2024, Amendment No. 4 thereto filed on July 15, 2024, Amendment No. 5 thereto filed on July 30, 2024, Amendment No. 6 thereto filed on August 14, 2024, Amendment No. 7 thereto filed on September 3, 2024, Amendment No. 8 thereto filed on September 11, 2024 and Amendment No. 9 thereto filed on December 17, 2024, the "Schedule 13D") by Todd Deutsch, Ted D. Kellner and, in the cases of Amendment No. 8 and 9 thereto, Paul W. Sweeney, and Amendment No. 9 thereto, Wayne Springate, with respect to the Common Stock, par value $0.001 per share, of AIM ImmunoTech Inc. (the "Company").
In this Amendment No. 10, Mr. Deutsch, Mr. Kellner, Mr. Sweeney and Mr. Springate are each a "Reporting Person" and, collectively, the "Reporting Persons." In the Initial Schedule 13D and all prior amendments, "Reporting Persons" refers to Mr. Deutsch and Mr. Kellner, except for Amendment No. 8, in which "Reporting Persons" refer to Mr. Deutsch, Mr. Kellner and Mr. Sweeney, and Amendment No. 9, in which "Reporting Persons" refer to Mr. Deutsch, Mr. Kellner, Mr. Sweeney and Mr. Springate. Capitalized terms used herein and not otherwise defined in this Amendment No. 10 shall have the meanings set forth in the Schedule 13D. This Amendment No. 10 amends Item 5 to the extent set forth below. </commentText>
</item1>
<item5>
<date5PercentOwnership>As a result of the termination of the agreement among the Reporting Persons, dated September 3, 2024 and amended September 11, 2024 and December 14, 2024, by its terms following the completion of the Company's annual meeting of stockholders held on December 17, 2024, following the final certification of voting results of the annual meeting on December 19, 2024, each of the Reporting Persons has ceased to be a part of any "group" within the meaning of the Securities Exchange Act of 1934, as amended, among or between the Reporting Persons that is the beneficial owner of more than 5% of the Company's outstanding Common Stock and, accordingly, each of the Reporting Persons has ceased to be the beneficial owner of more than 5% of the Company's outstanding Common Stock. The filing of this Amendment No. 10 represents the final amendment to the Schedule 13D and constitutes an exit filing for each of the Reporting Persons and the Reporting Persons as a group.</date5PercentOwnership>
</item5>
</items1To7>
<signatureInfo>
<signaturePerson>
<signatureReportingPerson>Todd Deutsch</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Todd Deutsch</signature>
<title>Todd Deutsch</title>
<date>12/23/2024</date>
</signatureDetails>
</signaturePerson>
<signaturePerson>
<signatureReportingPerson>Ted D. Kellner</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Ted D. Kellner</signature>
<title>Ted D. Kellner</title>
<date>12/23/2024</date>
</signatureDetails>
</signaturePerson>
<signaturePerson>
<signatureReportingPerson>Paul W. Sweeney</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Paul W. Sweeney</signature>
<title>Paul W. Sweeney</title>
<date>12/23/2024</date>
</signatureDetails>
</signaturePerson>
<signaturePerson>
<signatureReportingPerson>Wayne Springate</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Wayne Springate</signature>
<title>Wayne Springate</title>
<date>12/23/2024</date>
</signatureDetails>
</signaturePerson>
</signatureInfo>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
